Opportunities and Challenges in Early-Stage TB Drug Discovery: Targeting DNA Replication as a Case Study
The TB drug pipeline has begun to deliver new and repurposed drugs and combinations which have revolutionized the treatment of drug-resistant TB and shown that treatment-shortening is an achievable goal. Maintaining this momentum requires replenishment of the pipeline with high-quality ‘hit’ compoun...
Saved in:
| Main Authors: | Prof Valerie Mizrahi, Melissa Chengalroyen, Sasha Lynch, Mandy Mason |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | International Journal of Infectious Diseases |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971225000396 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-scarring drug discovery: potential targets and therapeutic opportunities
by: Meiling Feng, et al.
Published: (2025-12-01) -
A goldilocks computational protocol for inhibitor discovery targeting DNA damage responses including replication-repair functions
by: Davide Moiani, et al.
Published: (2024-11-01) -
The DNA replication checkpoint targets the kinetochore to reposition DNA structure-induced replication damage to the nuclear periphery
by: Tyler M. Maclay, et al.
Published: (2025-08-01) -
Integration of AI and ML in Tuberculosis (TB) Management: From Diagnosis to Drug Discovery
by: Sameeullah Memon, et al.
Published: (2025-06-01) -
Probing Redox Responses and DNA Interactions in Drug Discovery
by: Hüseyin Oğuzhan Kaya, et al.
Published: (2025-04-01)